Literature DB >> 4579666

Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.

N E Miller, P Clifton-Bligh, P J Nestel, H M Whyte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4579666

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Abnormal low density lipoproteins in children with familial hypercholesterolemia--effect of polyanion exchange resins.

Authors:  R Mordasini; F Twelsiek; P Oster; B Schellenberg; H Raetzer; C C Heuck; G Schlierf
Journal:  Klin Wochenschr       Date:  1978-08-15

Review 2.  Hypolipaemic drugs and coronary heart disease.

Authors:  A N Howard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

3.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

Review 4.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 5.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

6.  Noninvasive assessment of lipid disposition in treated and untreated atherosclerotic rabbits.

Authors:  L E DeForge; S W Schwendner; M R DeGalan; D S McConnell; R E Counsell
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

7.  Modification of the carcinogenic process in colorectal cancer by endogenous and exogenous factors: effect of colestipol hydrochloride on tumors induced by dimethylhydrazine.

Authors:  J P Daugherty
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.